Search research articles
Contact Us
Filters
Showing results (141-150 of 242) with videos related to
Page
of 25
Sort By:
Journal of Proteome Research
|
January 6, 2011
Protein pathway activation associated with sustained virologic response in patients with chronic hepatitis C treated with pegylated interferon (PEG-IFN) and ribavirin (RBV)
Zobair M Younossi, Dolores Limongi, Maria Stepanova, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 31, 2021
Serum Biomarkers are Associated With Atherosclerotic Cardiovascular Disease Among Patients With Nonalcoholic Fatty Liver Disease Undergoing Elective Angiography
Zobair M Younossi, Sean Felix, Thomas Jeffers, et al.
Clinics in Liver Disease
|
May 16, 2026
Metabolic Dysfunction-Associated Steatotic Liver Disease: Global Epidemiology, Patient-Reported Outcomes, and Economic Impact
James M Paik, Linda Henry, Khalid AlNaamani, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
October 14, 2018
French Patients with Hepatitis C Treated with Direct-Acting Antiviral Combinations: The Effect on Patient-Reported Outcomes
Patrice Cacoub, Marc Bourliere, Tarik Asselah, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine
|
July 15, 2024
Liver Transplantation Profile Among Teenagers in the United States
Saleh A Alqahtani, Maria Stepanova, Dipam Shah, et al.
Psychosomatics
|
March 15, 2011
Depression in patients with nonalcoholic fatty liver disease and chronic viral hepatitis B and C
Ali A Weinstein, Jillian Kallman Price, Maria Stepanova, et al.
International Journal of General Medicine
|
September 8, 2025
Associations Between Inflammatory and Catecholamine Markers and Clinical Outcomes in People with Post-Acute SARS-CoV-2 Infection
Lynn H Gerber, Micahel Estep, Leyla De Avila, et al.
Alimentary Pharmacology & Therapeutics
|
March 27, 2023
The combination of the enhanced liver fibrosis and FIB-4 scores to determine significant fibrosis in patients with nonalcoholic fatty liver disease
Zobair M Younossi, Maria Stepanova, Sean Felix, et al.
Journal of Hepatology
|
December 17, 2013
Minimal impact of sofosbuvir and ribavirin on health related quality of life in chronic hepatitis C (CH-C)
Zobair M Younossi, Maria Stepanova, Linda Henry, et al.
Hepatology Communications
|
February 28, 2022
Nonalcoholic steatohepatitis is the most common indication for liver transplantation among the elderly: Data from the United States Scientific Registry of Transplant Recipients
Maria Stepanova, Khaled Kabbara, Denise Mohess, et al.
Page
of 25
Search research articles
Search
Showing results (141-150 of 242) with videos related to
Sort By:
Page
of 25
Journal of Proteome Research
|
January 6, 2011
Protein pathway activation associated with sustained virologic response in patients with chronic hepatitis C treated with pegylated interferon (PEG-IFN) and ribavirin (RBV)
Zobair M Younossi, Dolores Limongi, Maria Stepanova, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 31, 2021
Serum Biomarkers are Associated With Atherosclerotic Cardiovascular Disease Among Patients With Nonalcoholic Fatty Liver Disease Undergoing Elective Angiography
Zobair M Younossi, Sean Felix, Thomas Jeffers, et al.
Clinics in Liver Disease
|
May 16, 2026
Metabolic Dysfunction-Associated Steatotic Liver Disease: Global Epidemiology, Patient-Reported Outcomes, and Economic Impact
James M Paik, Linda Henry, Khalid AlNaamani, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
October 14, 2018
French Patients with Hepatitis C Treated with Direct-Acting Antiviral Combinations: The Effect on Patient-Reported Outcomes
Patrice Cacoub, Marc Bourliere, Tarik Asselah, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine
|
July 15, 2024
Liver Transplantation Profile Among Teenagers in the United States
Saleh A Alqahtani, Maria Stepanova, Dipam Shah, et al.
Psychosomatics
|
March 15, 2011
Depression in patients with nonalcoholic fatty liver disease and chronic viral hepatitis B and C
Ali A Weinstein, Jillian Kallman Price, Maria Stepanova, et al.
International Journal of General Medicine
|
September 8, 2025
Associations Between Inflammatory and Catecholamine Markers and Clinical Outcomes in People with Post-Acute SARS-CoV-2 Infection
Lynn H Gerber, Micahel Estep, Leyla De Avila, et al.
Alimentary Pharmacology & Therapeutics
|
March 27, 2023
The combination of the enhanced liver fibrosis and FIB-4 scores to determine significant fibrosis in patients with nonalcoholic fatty liver disease
Zobair M Younossi, Maria Stepanova, Sean Felix, et al.
Journal of Hepatology
|
December 17, 2013
Minimal impact of sofosbuvir and ribavirin on health related quality of life in chronic hepatitis C (CH-C)
Zobair M Younossi, Maria Stepanova, Linda Henry, et al.
Hepatology Communications
|
February 28, 2022
Nonalcoholic steatohepatitis is the most common indication for liver transplantation among the elderly: Data from the United States Scientific Registry of Transplant Recipients
Maria Stepanova, Khaled Kabbara, Denise Mohess, et al.
Page
of 25